Sorafenib
Treatment for Liver Cancer Due To Alcohol Use
Typical Dosage: 400mg orally twice daily
Effectiveness
55%
Safety Score
55%
Clinical Trials
8
Participants
4.5K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
400mg orally twice daily
Time to Effect
Stable disease or response within 1-3 months
Treatment Duration
Until disease progression or unacceptable toxicity
Evidence Quality
HIGHNumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
4(Treat 4 patients to see 1 additional serious adverse event)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$130,000
Monitoring:$12,000
Side Effect Mgmt:$5,000
Total Annual:$147,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POORICER
$200,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$4,900,000
Cost per Remission
$14,700,000
Sorafenib Outcomes
for Liver Cancer Due To Alcohol Use
Efficacy Outcomes
Overall Effectiveness
+55%
Response Rate
+3%
Remission Rate
+1%
Common Side Effects
Hand-foot skin reaction
+50%
Diarrhea
+45%
Fatigue
+35%
Rash
+25%
Hypertension
+15%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov